Jury member of AI & Digital Health Investor Panel

Aishwarya (Aishu) Parthasarathy | Investment Analyst | Sofinnova Partners

Aishu is an investor with a decade of experience in academia, specializing in leveraging data and computation to advance neuroscience. During her time in academia, she published high-impact papers and secured grants. In 2022, she transitioned to Venture Capital at Biogeneration Ventures, applying their expertise in life sciences to assess investment opportunities. Since October 2023, as an Analyst at Sofinnova Partners in the Digital Medicine Strategy, she uses her scientific and investment experience to evaluate and shape the future of digital medicine through strategic investments.

About Sofinnova Partners

Established in 1972, Sofinnova Partners has been a driving force behind over 500 companies for more than 50 years, fostering global market leaders. With over €2.5 billion under management today, over several strategies, the firm actively engages across the full spectrum of life sciences investments, from seed to later-stage, emphasizing healthcare and sustainability. Each fund reflects our prowess in identifying opportunities and realizing their potential through dedicated teams and strategic approaches. Notably, the Sofinnova Digital Medicine Strategy supports early-stage startups at the convergence of biology, data, and computation.